Epigenetic Mechanisms in Bone Health and Osteoporosis

Bone homeostasis relies on a dynamic balance between bone-forming osteoblasts and bone-resorbing osteoclasts. Epigenetic mechanisms—heritable modifications that regulate gene expression without altering the DNA sequence—play a central role in this process. DNA methylation at promoter CpG islands can silence key osteogenic genes, while histone modifications modulate chromatin accessibility to transcription factors such as RUNX2. Non-coding RNAs, including microRNAs and long non-coding RNAs, fine-tune signalling pathways by targeting messenger RNAs or recruiting chromatin-remodelling complexes. These layers of regulation integrate environmental cues such as ageing, hormonal changes and mechanical loading to adjust mesenchymal stem cell fate towards osteoblast or adipocyte lineages. Disruption of epigenetic homeostasis contributes to osteoporosis by impairing osteogenic differentiation, promoting marrow adiposity and enhancing osteoclastic activity. Understanding the interplay between DNA methylation, histone modification and non-coding RNAs is shedding light on the molecular pathogenesis of osteoporosis and opening new avenues for epigenetic therapies to restore bone strength.

Research from Nature Portfolio

Investigation into the secreted Wnt antagonist sFRP4 has revealed its critical function as a balancer of Wnt signalling in bone development and remodelling. In genetically modified mouse models, loss of sFRP4 led to enhanced trabecular bone mass and increased osteogenic activity, while preserving bone integrity during ageing. Histological and micro-CT analyses demonstrated that sFRP4 deficiency augments endocortical bone formation by modulating both osteoblast and osteoclast function, highlighting a potential target for therapies aimed at preventing age-related bone loss.

Epigenetic Mechanisms in Bone Health and Osteoporosis publication trend

The graph below shows the total number of articles in epigenetic mechanisms in bone health and osteoporosis across all publications each year (not limited to Nature Index journals).

Technical terms

DNA methylation: Covalent addition of methyl groups to cytosine residues in DNA, typically leading to transcriptional repression.

Histone modification: Post-translational changes to histone proteins, such as acetylation or methylation, that influence chromatin structure and gene expression.

MicroRNA (miRNA): Small non-coding RNA molecules that regulate gene expression by promoting degradation of target messenger RNAs or inhibiting their translation.

Long non-coding RNA (lncRNA): RNA transcripts longer than 200 nucleotides without protein-coding potential, involved in chromatin remodelling and transcriptional regulation.

Bone marrow mesenchymal stem cells (BMSCs): Multipotent progenitor cells in the bone marrow capable of differentiating into osteoblasts, chondrocytes or adipocytes.

Osteoblast: Bone-forming cell responsible for synthesising and mineralising bone matrix.

Osteoclast: Multinucleated cell derived from haematopoietic precursors that resorbs bone matrix.

Extracellular vesicles: Membrane-bound particles released by cells that carry proteins, lipids and nucleic acids to modulate recipient cell behaviour.

References

1. Epigenetic Mechanisms in Bone Biology and Osteoporosis: Can They Drive Therapeutic Choices?. International Journal of Molecular Sciences (2016).
2. sFRP4-dependent Wnt signal modulation is critical for bone remodeling during postnatal development and age-related bone loss. Scientific Reports (2016).
3. Bmi‐1 Epigenetically Orchestrates Osteogenic and Adipogenic Differentiation of Bone Marrow Mesenchymal Stem Cells to Delay Bone Aging. Advanced Science (2024).
4. Hypermethylation of Bmp2 and Fgfr2 Promoter Regions in Bone Marrow Mesenchymal Stem Cells Leads to Bone Loss in Prematurely Aged Mice. Aging and Disease (2024).
5. Unveiling the intricacies of bone homeostasis: Epigenetic regulation, extracellular vesicles, and angiogenesis integration. Extracellular Vesicle (2024).